What was recalled
If you have been taking prescription medication for high blood pressure or fluid retention recently, it is important to pause and check your medicine cabinet. The U.S. Food and Drug Administration (FDA) has issued a recall involving Chlorthalidone Tablets, USP, 25 mg. This specific batch was manufactured by Inventia Healthcare Limited and distributed under the brand name Inventia Healthcare. While Chlorthalidone is a well-established thiazide diuretic commonly prescribed to manage hypertension and edema, not every bottle on the market is safe. The FDA’s alert targets a precise set of products that failed to meet strict quality control standards during the manufacturing process.
To help you identify exactly which bottles are affected, we need to look at the specific details provided in the official recall notice. This is not a blanket recall of all Chlorthalidone 25 mg tablets; it is limited to a single National Drug Code (NDC) and batch number. The recalled product is packaged as 100 Tablets per bottle, labeled for prescription use only (Rx only). The critical identifier you must look for on your bottle label is the NDC: 64980-599-01. Alongside this code, you must verify the Batch Number, which is listed as RISA24002. If your bottle does not match both of these identifiers exactly, it is likely not part of this specific recall event.
Another vital detail to check is the expiration date printed on the packaging. The recalled units have an expiration date of April 2027 (04/2027). While a future expiration date might make the medication appear fresh and viable, it does not guarantee that the drug’s chemical composition remains stable or effective throughout its intended shelf life in this specific instance. The recall was initiated on September 3, 2026, indicating that Inventia Healthcare Limited and the FDA recognized the issue relatively soon after distribution began. Understanding the timeline helps clarify why prompt action is necessary, even if you recently purchased the item.
The scope of this recall is nationwide, meaning these bottles could have been distributed to pharmacies, hospitals, or clinics anywhere in the United States. There is no specific state restriction mentioned in the FDA record, so residents across all states who possess a bottle matching the NDC 64980-599-01 and Batch # RISA24002 should treat this alert as applicable to them. The classification of this recall is Class II, which suggests that while the product is not expected to cause serious adverse health consequences or death, it could result in minor temporary medical problems or require correction. This classification underscores the importance of verifying your medication rather than ignoring the notice. If you are unsure whether your bottle is included, do not guess; use the NDC and batch number as your primary tools for verification.
The hazard, explained
To understand why this recall matters, we first need to look at what is supposed to happen inside your body when you take Chlorthalidone. This medication belongs to a class of drugs called thiazide diuretics, which are commonly prescribed to manage high blood pressure (hypertension) and fluid retention (edema). In simple terms, it works by helping your kidneys remove extra sodium and water from your body through urine. When this process works correctly, it reduces the volume of blood circulating through your vessels, thereby lowering the pressure against your artery walls. For millions of people, this reliable mechanism is the key to preventing serious cardiovascular events like strokes or heart attacks.
The core issue with the recalled Inventia Healthcare Limited batch is a failure in "dissolution specifications." Dissolution is the process by which a solid tablet breaks down and releases its active ingredient into a liquid environment so your body can absorb it. Think of the pill as a tightly packed sponge that must fully soak up water before it can release the medicine. The FDA’s testing revealed that these specific 25 mg tablets did not break down properly in laboratory simulations designed to mimic the conditions of the human stomach and intestines. When a tablet fails dissolution, it means the drug is trapped inside the solid matrix rather than being released for absorption.
This physical failure leads to a significant chemical problem: under-dosing. Because the Chlorthalidone is not dissolving as intended, your body receives less of the active ingredient than what is printed on the bottle. This is particularly dangerous because Chlorthalidone has a long half-life, meaning it stays in your system for a prolonged period. If the daily dose is effectively lower than prescribed over several days or weeks, your blood pressure may creep back up without you noticing any immediate symptoms. Hypertension is often called the "silent killer" precisely because it rarely shows obvious signs until damage is done.
Furthermore, inconsistent dissolution can lead to unpredictable therapeutic effects. You might have days where the pill works adequately and days where it fails entirely, making your blood pressure erratic rather than stable. For patients relying on this medication to keep their cardiovascular system in check, this unpredictability undermines the entire purpose of treatment. While the recall does not indicate that the tablets contain harmful toxins or incorrect amounts of the drug itself, the inability to deliver the correct dose reliably poses a direct risk to heart health and blood pressure control. This is why the FDA classified this as a Class II recall: while not immediately life-threatening in every instance, it presents a substantial risk of injury if the condition being treated worsens due to lack of effective medication.
Who is most at risk
To understand who is truly at risk in this specific recall, we first need to look at the nature of the product itself. Chlorthalidone is a prescription medication classified as a thiazide diuretic, commonly known as a "water pill." It is primarily prescribed to manage high blood pressure (hypertension) and to help the body eliminate excess salt and water, which can also be used to treat fluid retention caused by heart failure or other conditions. Because this is an Rx-only drug, the individuals most directly involved in this recall are adults who have been diagnosed with cardiovascular issues or hypertension and are currently under a doctor’s care. The distribution pattern confirms that these bottles were sold nationwide, meaning there is no specific geographic region to exclude from consideration.
The core of the risk lies in what "failed dissolution specifications" actually means for a patient taking this medication. Dissolution refers to how well and how quickly a tablet breaks down in the stomach so the drug can be absorbed into the bloodstream. When a batch fails this test, it generally means the pills are not releasing their active ingredients at the expected rate or intensity. For someone relying on Chlorthalidone to keep their blood pressure under control, this inconsistency is significant. If the tablet dissolves too slowly or incompletely, the patient may receive less medication than prescribed. This can lead to uncontrolled hypertension, which silently strains the heart and blood vessels over time. Conversely, in some failure modes, there could be a rapid dump of the drug, leading to sudden drops in blood pressure. Both scenarios pose serious health threats, but the unpredictability is the primary danger.
Certain groups are particularly vulnerable to these fluctuations. Older adults, who make up a large portion of the population prescribed for hypertension, often have more sensitive cardiovascular systems and may be taking multiple other medications. For them, even a slight deviation in drug efficacy can lead to dizziness, falls, or worsened heart conditions. Additionally, individuals with pre-existing kidney issues or electrolyte imbalances are at higher risk because diuretics directly affect the body’s balance of sodium, potassium, and water. If the dosage is inconsistent due to poor dissolution, it becomes much harder for their bodies to maintain homeostasis.
It is also important to note that while this recall involves a Class II classification—which typically indicates a situation where use might cause temporary or medically reversible health problems—the stakes are still high for anyone dependent on stable blood pressure management. Children are not the primary demographic for this specific drug, so the risk profile is distinctly focused on adult patients with chronic conditions. If you or a loved one falls into these categories and has been managing hypertension with Inventia Healthcare’s Chlorthalidone, the potential for untreated symptoms makes timely action crucial.
How to tell if you have the recalled item
Identifying whether the prescription bottle in your medicine cabinet matches this specific recall requires a careful, methodical check of several key details printed directly on the packaging. Because this is a Class II recall involving Chlorthalidone Tablets, USP, manufactured by Inventia Healthcare Limited, you cannot rely on general impressions or brand names alone to rule it out. Instead, you need to physically locate and verify four distinct pieces of information: the National Drug Code (NDC), the batch number, the expiration date, and the manufacturer’s name. If any one of these details does not match the official records, your bottle is likely safe from this specific recall event.
Start by looking at the side or back label of your white prescription bottle. The most critical identifier is the National Drug Code, often abbreviated as NDC. This unique nine-digit number serves as a product identifier for FDA-regulated drugs. For this recall, you must look specifically for the NDC 64980-599-01. It is formatted in three segments separated by hyphens. The first segment, 64980, identifies the labeler (Inventia Healthcare). The second segment, 599-01, identifies the specific product strength and package size. If your bottle displays a different NDC, it is not part of this recall.
Next, examine the label for the batch or lot number, which tracks the specific production run. In this case, you are looking for the batch identifier RISA24002. This alphanumeric code is often printed near the expiration date or on a separate line labeled "Lot" or "Batch." Following that, check the expiration date, which indicates when the manufacturer guarantees the drug’s full potency and safety. For the affected units, the expiration date is 04/2027. It is important to note that while other bottles may share the same NDC or manufacturer, they will not be recalled unless they also have this exact batch number. A different batch number means your medication was produced in a separate run and is not subject to this specific dissolution failure issue.
Finally, verify the product description and quantity. The recalled item consists of Chlorthalidone Tablets, USP, 25 mg, packaged in bottles containing 100 Tablets per bottle. This is a prescription-only (Rx only) medication. While the manufacturer is listed as Inventia Healthcare Limited, be cautious: other pharmaceutical companies may produce Chlorthalidone with similar packaging colors or sizes. Therefore, the NDC and batch number remain your most reliable verification tools. If you cannot find these details clearly printed on your bottle, or if they do not match the combination of NDC 64980-599-01, Batch RISA24002, and Exp Date 04/2027, your medication is not part of this recall. If you are unsure, do not guess; contact your pharmacist or the manufacturer directly for confirmation before taking any action.
What to do — step by step
If you currently have the recalled Chlorthalidone Tablets, USP, 25 mg manufactured by Inventia Healthcare Limited, your immediate priority is to ensure that these specific units do not enter your body. Because the recall stems from a failure to meet dissolution specifications, the medication may not release its active ingredient correctly. This means the drug might not work as intended, which can be particularly dangerous for a condition like high blood pressure where consistent dosing is critical. While the official FDA recall notice does not explicitly state the specific remedy—such as whether you should return the product for a refund or simply dispose of it—you must take proactive steps to protect your health.
- Stop taking the medication immediately. Do not wait for your next scheduled refill. If you are relying on Chlorthalidone to manage hypertension or edema, stopping suddenly can cause your blood pressure to spike. This is a medical urgency, not just an administrative one. Contact your prescribing physician or healthcare provider right away to discuss alternative treatments. They may prescribe a different brand or a different class of diuretic entirely to ensure your condition remains stable during this transition.
- Identify your specific bottle with precision. The recall affects only specific batches and NDCs. Verify that you possess the exact product listed in the notice: Chlorthalidone Tablets, USP, 25 mg, in a bottle of 100 tablets, manufactured by Inventia Healthcare Limited. You must check the National Drug Code (NDC), which is 64980-599-01, and the Batch Number, RISA24002. The expiration date on your bottle should be 04/2027. If your bottle does not match all these details exactly, it is likely safe to continue using it, but double-check with your pharmacist if you are uncertain.
- Consult your pharmacy for guidance. Since the remedy is not stated in the public recall data, your local pharmacy is your best resource. They can confirm whether they have records of your purchase and may be able to facilitate a replacement or refund directly through their distribution channels. Pharmacies often have established protocols for handling manufacturer recalls and can advise you on the most efficient way to resolve this without interrupting your care.
- Do not flush the medication unless instructed. Generally, it is safer to return recalled drugs to a pharmacy or a designated take-back site rather than disposing of them in household trash or toilets, which can contaminate water supplies. However, if you cannot return them, follow local guidelines for safe disposal. Keep the bottle intact so that the identifying information remains visible.
- Monitor your health closely. Pay attention to any changes in your blood pressure readings or symptoms while you are transitioning to a new treatment plan. If you experience dizziness, fainting, or other concerning symptoms, seek medical attention promptly. Your safety is the primary concern here, not just the compliance with a recall notice.
Your refund, repair, or replacement options
When you receive a recall notice, your immediate concern is often the logistical question of what happens next with the product in your possession. In this specific instance regarding Inventia Healthcare Limited’s Chlorthalidone Tablets, USP, 25 mg, the official FDA recall documentation does not explicitly state a standardized remedy such as a direct refund, a prepaid return label, or a replacement shipment. This absence of a specified remedy is not uncommon in Class II drug recalls, particularly those involving manufacturing specifications like failed dissolution tests. Instead of a blanket policy issued by the manufacturer at this time, the primary "remedy" prescribed by regulatory standards is the immediate cessation of use and proper disposal to ensure patient safety. It is crucial to understand that for prescription medications, the concept of a "refund" through a standard retail return process is often complicated by controlled substance regulations and pharmacy policies designed to prevent diversion or misuse.
If you have this specific batch of medication, your first step should be to contact the pharmacy where you originally filled the prescription. Pharmacists are trained to handle recall situations and can guide you on how to safely dispose of the unused tablets. They can also verify whether they have received a direct communication from Inventia Healthcare Limited regarding inventory returns or replacements for their stock. For patients who still possess bottles, the goal is not necessarily to get your money back immediately, but to ensure that no further doses are taken. Since Chlorthalidone is a prescription drug used to treat high blood pressure and fluid retention, stopping the medication abruptly can have health implications. Therefore, you must consult your healthcare provider before making any changes to your treatment plan. Your doctor may need to prescribe an alternative medication from a different manufacturer or lot number to ensure your condition remains managed without interruption.
In terms of financial restitution, if you paid for this specific bottle out-of-pocket and it was part of the recalled distribution pattern, you should inquire with both your pharmacy and your health insurance provider. Some pharmacies may offer store credit or refunds as a customer service gesture, even if not mandated by the recall notice itself. However, do not assume that a refund is automatic. The recall information provided does not list a consumer hotline or a specific website for filing claims. This means that any financial recovery process would likely be handled on a case-by-case basis between you, your pharmacy, and potentially the manufacturer’s legal or quality assurance departments if they initiate a broader compensation program in the future. For now, the priority remains health safety over financial reimbursement.
To navigate this effectively, keep your bottle handy with the NDC (64980-599-01) and Batch Number (RISA24002). These identifiers are essential for any pharmacy or insurance representative to verify that your specific product is indeed part of the recall. Do not attempt to sell or donate the medication, as this poses a significant safety risk to others. Instead, follow local guidelines for pharmaceutical disposal, which often involve take-back programs at local law enforcement stations or authorized collectors. This ensures that the failed-dissolution tablets do not enter the environment or the hands of anyone who might rely on their efficacy for their health.
What can happen if you ignore it
When a medication fails to meet its dissolution specifications, the primary concern is not that the pill is "bad" in the sense of being contaminated or poisonous, but rather that it may not work as intended. Chlorthalidone is a thiazide diuretic commonly prescribed to manage high blood pressure (hypertension) and fluid retention associated with heart failure. Because it works by helping your kidneys remove excess salt and water from your body, its effectiveness relies heavily on the drug being fully released into your digestive system so it can enter your bloodstream. If the tablets do not dissolve properly, you may receive a significantly lower dose than what is written on the bottle, or perhaps no active medication at all.
The real-world consequence of using a non-compliant batch like this one is that your blood pressure may remain uncontrolled. Hypertension is often called the "silent killer" because it rarely shows obvious symptoms until significant damage has occurred. If you continue to take Chlorthalidone tablets that are failing to dissolve, you might feel fine while your internal health deteriorates. Uncontrolled high blood pressure puts steady, excessive force on your artery walls, which can lead to serious cardiovascular events over time. This includes an increased risk of stroke, heart attack, and heart failure. While a single missed dose is unlikely to cause immediate harm, relying on ineffective medication for days or weeks allows these risks to accumulate.
Additionally, because Chlorthalidone helps manage fluid balance, inconsistent absorption can lead to fluctuations in your electrolyte levels, such as potassium and sodium. For individuals with heart conditions, this instability can trigger irregular heartbeats (arrhythmias) or worsen existing symptoms like shortness of breath or swelling in the legs and ankles. You might notice that your usual routine no longer keeps you steady, leading to fatigue or dizziness, which are signs that your treatment plan is failing.
It is also important to remember that hypertension often requires a consistent therapeutic level of medication in your blood. If the drug dissolves too slowly or incompletely, your body may not maintain the necessary concentration to protect your organs. This creates a dangerous gap in your care where your vital organs are exposed to pressure they should be shielded from. Ignoring the recall does not make the problem go away; it simply means you are continuing to rely on a product that has been flagged by the FDA as unable to guarantee its labeled strength.
While there have been no reported incidents of injury or illness linked specifically to this recall as of the date listed, the potential for harm is rooted in the nature of the hazard itself. The risk is not acute toxicity but rather therapeutic failure. By ignoring the notice, you are essentially gambling with your long-term cardiovascular health on a product that has not passed its quality checks. The safest path is to assume the medication may be ineffective and take steps to protect your health immediately.